 |
Michael H. Farrell, MD
Assistant Professor, Medicine
Medicine-General Internal Medicine, Pediatrics and Population Health-Bioethics
|
"My research and professional interests focus on population-scale methods for quality assurance of risk communication, especially surrounding the use of screening tests which may have unforeseen or unexpected implications. As both an adult and pediatric health care provider, I have studied communication prior to cancer screening tests for adults (prostate-specific antigen and mammography) and communication following newborn genetic screening (for cystic fibrosis and sickle cell hemoglobinopathy). I recently completed a five-year mentored scientist development award to study ways to assess the processes and outcomes of communication following newborn genetic screening. I am currently funded by my first NIH R01 grant that uses methods developed in the development award to assess communication processes and outcomes across the state of Wisconsin after newborn screening. I am using a method of my own design called the "Brief Standardized Communication Assessment" (BSCA) to analyze physician risk communication against a series of "communication quality indicators." I am also delighted to be part of several other research projects, including a new study funded by the Healthier Wisconsin Educational Leadership program (with Dr. LuAnn Moraski in the Department of Pediatrics), and a groundbreaking evaluation of the use of a self-reflective journaling technique with medical students. I am also active in several teaching and service activities at the Medical College and the Primary Care Initiative.”
Representative Publications
Farrell MH, Certain L, Farrell PM. 2001. Genetic counseling and Risk Communication Services of Newborn Screening Programs. Arch Ped Adol Med 155(2): 120-126.
Farrell MH, Foody JM, Krumholz HM: beta-Blockers in Heart Failure: Clinical Applications. JAMA 2002;287(7):890-897.
Foody JM, Farrell MH, Krumholz HM: beta-Blocker Therapy in Heart Failure: Scientific Review. JAMA 2002;287(7):883-889.
Bobadilla JL, Farrell MH, Farrell PM. Applying CFTR Molecular Genetics to Facilitate the Diagnosis of Cystic Fibrosis Through Screening. Adv Pediatr 2002; 49:131-190.
Farrell MH, Murphy MA, Schneider CE. How Underlying Patient Beliefs Can Affect Physician-Patient Communication about Prostate-Specific Antigen. Eff Clin Pract 2002; 5: 120-129.
Farrell MH, Farrell PM. Newborn Screening for Cystic Fibrosis: Ensuring More Good than Harm (Invited commentary). J Pediatr 2003; 143(6): 707-712.
Rosenbaum JR, Bradley EH, Holmboe ES, Farrell MH, Krumholz HM. Sources of Conflict in Medical Housestaff Training. Am J Medicine 2004; 116:402-407.
Doolittle BR, Farrell MH. The Association Between Spirituality and Depression in an Urban Clinic. Prim Care Companion J Clin Psychiatry 2004; 6(3):114-118.
Farrell MH, La Pean A, Ladouceur LK. The Content of Communication by Residents After Newborn Genetic Screening. Pediatrics 2005; 116: 1492-1498.
La Pean A, Farrell MH. Initially Misleading Communication of Carrier Results after Newborn Genetic Screening. Pediatrics 2005; 116: 1499-1505
Gross CP, Filardo G, Singh HS, Freedman AN, Farrell MH. The Relation Between Projected Breast Cancer Risk, Perceived Cancer Risk, and Mammography Use. Results from the National Health Interview Survey. J Gen Intern Med 2006; 21(2): 158-164
Farrell MH, Kuruvilla P. Assessment of understanding by pediatric residents during counseling about newborn screening results. Arch Pediatr Adolesc Med 2008; 162(3): 199-204.
Farrell MH, Deuster L, Donovan J, Christopher SA. Pediatric residents' use of jargon during counseling about newborn genetic screening results. Accepted/in press, Pediatrics Aug 2008.
Deuster L, Christopher SA, Donovan J, Farrell MH. A Method to Quantify Residents’ Jargon Use during Counseling of Standardized Patients about Cancer Screening. Accepted/in press, J Gen Intern Med 2008.